Spero Therapeutics Inc (SPRO)
1.16
-0.03
(-2.52%)
USD |
NASDAQ |
Nov 22, 16:00
1.175
+0.02
(+1.29%)
After-Hours: 20:00
Spero Therapeutics Revenue (Annual): 96.74M for Dec. 31, 2023
Revenue (Annual) Chart
Historical Revenue (Annual) Data
Date | Value |
---|---|
December 31, 2023 | 96.74M |
December 31, 2022 | 48.58M |
December 31, 2021 | 3.07M |
Date | Value |
---|---|
December 31, 2020 | 0.258M |
December 31, 2019 | 4.742M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Annual) Range, Past 5 Years
0.258M
Minimum
2020
96.74M
Maximum
2023
30.68M
Average
4.742M
Median
2019
Revenue (Annual) Benchmarks
CytomX Therapeutics Inc | 101.21M |
Johnson & Johnson | 85.16B |
Arbutus Biopharma Corp | 18.14M |
Equillium Inc | 36.08M |
NovaBay Pharmaceuticals Inc | 14.73M |